ALPRE.PA

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Diagnostics & Research

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$2M	+51.9%	$-1.53	$-1.53–$-1.53	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
ALPRE.PAPredilife S.A.	$1.02	+0.00%	$4M	—
AELIS.PAAelis Farma S.A.	$0.95	-5.00%	$13M	—
ALAMA.PAAMA Corporation Plc	$0.16	+0.31%	$9M	—
ALBIO.PABiosynex S.A.	$0.92	+2.00%	$17M	—
ALBLU.PABluelinea S.A.	$0.15	-11.76%	$3M	—
ALEMG.PAEuromedis Groupe	$5.10	+0.00%	$15M	—
ALINS.PAIntrasense S.A.	$0.25	+0.40%	$13M	—

Source: Financial Modeling Prep · peers by sector/industry

Predilife S.A.

Founded in 2004 and headquartered in Villejuif, France, Predilife S.A. specializes in devising and commercializing sophisticated medical technologies and analytical models. The company's core offerings include preventative healthcare solutions and comprehensive breast screening tests. Among its notable products are MammoRisk, a diagnostic tool designed to forecast an individual's risk of developing breast cancer; DenSeeMammo, software for evaluating breast tissue density; and a specialized medical device developed for predicting prostate cancer risk.

www.predilife.com

Employees: 21
IPO / List date: Dec 21, 2018
HQ: FR

Held by traders on TradeandTell

No one on the platform currently holds ALPRE.PA.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in ALPRE.PA as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded ALPRE.PA yet.